Get With The Guidelines-Stroke Participation Has Improved Stroke Care
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 31, 2024 -- For patients with stroke and transient ischemic attack, The Get With The Guidelines-Stroke participation is associated with sustained improvement in care and outcomes, according to a study published online Oct. 21 in Stroke.
Ying Xian, M.D., Ph.D., from UT Southwestern Medical Center in Dallas, and colleagues examined patient characteristics, adherence to performance measures, and in-hospital outcomes in patients hospitalized with stroke in The Get With The Guidelines-Stroke hospitals from 2003 to 2022. Temporal changes in performance measure adherence and clinical outcomes were quantified over time.
A total of 7,837,849 stroke cases were entered into the registry during the 20 years of the program: 69.2 percent ischemic strokes, 3.9 percent subarachnoid hemorrhages, 11.5 percent intracerebral hemorrhages, and 15.3 percent transient ischemic attacks. The researchers found significantly sustained improvements in all performance metrics except for antithrombotics at discharge (baseline performance >92 percent), regardless of type of cerebrovascular event. Independent of patient and hospital characteristics for each type of cerebrovascular event, there was a sustained increase in odds of receiving each performance measure over time in a multivariable analysis. There were temporal trends that patients were less likely to be discharged to a skilled nursing facility after risk adjustment; for ischemic stroke only, they were more likely to be discharged directly home.
"These findings provide compelling evidence to support continuous efforts in improving stroke care and outcomes in the United States and globally," the authors write.
Several authors disclosed ties to the pharmaceutical industry; The Get With The Guidelines-Stroke program is sponsored by pharmaceutical companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
FRIDAY, June 6, 2025 -- For patients who undergo percutaneous coronary intervention (PCI) and discontinue dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.